Furthermore, pathologically deregulated erythropoiesis (polycythemia vera) is associated with an abnormal increase in the activation of the MAPK and PI3K/AKT pathways [46] likely caused by the point mutation in JAK2 kinase. The gene discussed is JAK2; the disease is acquired polycythemia vera.